AQA
UTHR icon

Alpha Quant Advisors’s United Therapeutics UTHR Stock Holding History

Alpha Quant Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$33K Hold
285
– – 0.03% 135
2018
Q4 		$31K Buy
+285
New +$33K 0.03% 133

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alpha Quant Advisors's UTHR Position: Q1 2019 in Review

Alpha Quant Advisors held its United Therapeutics (UTHR) position steady in Q1 2019 at 285 shares worth $33K. The position accounts for 0.03% of the portfolio, ranked #135.

Alpha Quant Advisors first reported a position in UTHR in Q4 2018 and has held it in 2 quarters since. 378 funds tracked by Wall St. Rank hold UTHR as of Q1 2019.

  • Alpha Quant Advisors held 285 shares of United Therapeutics worth $33K as of Q1 2019.
  • Alpha Quant Advisors left its United Therapeutics share count unchanged in Q1 2019.
  • United Therapeutics made up 0.03% of Alpha Quant Advisors's portfolio in Q1 2019, its #135 holding.
  • Alpha Quant Advisors first reported a position in United Therapeutics in Q4 2018 and has held it in 2 quarters since.
  • 378 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2019.

Based on Alpha Quant Advisors's 13F filing for Q1 2019, filed 8 May 2019.